RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
RxSight (NASDAQ: RXST) will present at the 25th Annual Needham Virtual Healthcare Conference.
Rhea-AI Summary
RxSight (NASDAQ: RXST) will present at the 25th Annual Needham Virtual Healthcare Conference. Management will participate in a fireside chat on April 16, 2026 at 8:00 a.m. PT. A live and archived webcast will be available on the company investor relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – RXST
In the Apr 6 session, RXST gained 5.72%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference iteration
- 25th Annual
- Needham Virtual Healthcare Conference
- Conference date
- April 16, 2026
- RxSight fireside chat at Needham Virtual Healthcare Conference
- Presentation time
- 8:00 a.m. Pacific Time
- Scheduled time for management fireside chat
Historical Context
-
2025 revenue decline and wider net loss with 2026 guidance outlined.
-
Announcement of upcoming Q4 and 2025 results call date and time.
-
Preliminary 2025 revenue above prior guidance and new CFO appointment.
-
Notice of J.P. Morgan conference presentation without new financial data.
-
Planned departure of long-serving CFO and transition to successor.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, April 16, 2026, at 8:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.